Cognitive dysfunction in kidney cancer survivors is linked to treatment burden, stress, and fatigue, affecting daily ...

During a live event, Kathryn E. Beckermann, MD, PhD, and participants discussed whether risk stratification factors into the ...

Janux provided a program update on its Phase 1 study of JANX008, an EGFR-targeted TRACTr, following Phase 1a completion and ...

Symptoms of stage 3 RCC vary; some patients experience blood in the urine, flank pain, fatigue, weight loss, or a palpable ...

In a heartfelt revelation, Malaysian actress Zara Zya has opened up about her recent health struggles, disclosing that she has been diagnosed with stage one renal cell carcinoma, a type of kidney ...

In a heartfelt revelation, actress Zara Zya has shared her battle with stage one kidney cancer, specifically renal cell carcinoma. This announcement serves as a poignant reminder of the importance of ...

Bristol Myers and BioNTech Advance Kidney Cancer Combo Study With New Early-Stage Trial ...

Werewolf Therapeutics (HOWL) announced a pipeline update, including a review of recent data for its INDUKINE programs, and a business overview of ...

WTX-124 initial Phase 1b expansion arm data showed 30% overall response rate as a monotherapy in a defined subset of post-ICI advanced or metastatic cutaneous melanoma patients, with potential best-in ...

Cytoreductive nephrectomy merits further consideration in appropriately risk-stratified, surgically fit patients with mRCC.

The company plans to launch a Phase I trial of its lead autologous cell therapy for renal cell carcinoma in 2026.

Treatment with glucagon-like peptide-1 receptor agonists was associated with lower probabilities of heart, kidney, and lung complications after partial nephrectomy for RCC.